Common heart drug may slow progression of Huntington's disease

A common heart drug may slow the progression of Huntington's disease (HD), according to a new study by University of Iowa Health Care researchers.

Using clinical information from a large, observational database of over 21,000 people with HD, the UI team found that the use of beta-blocker drugs - commonly used to treat heart and blood pressure issues - was associated with both a significantly later onset of HD symptoms for people in the pre-symptomatic stages, and a slower rate of symptom worsening for those with symptoms.

from Breaking World Pharma News https://ift.tt/fCDr7Iz